Diagnos Laboratorium Utama Tbk. vs Trimitra Propertindo Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Trimitra Propertindo Tbk. trades at Rp81 (market cap 226.2B, 257.27M 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is the larger of the two by market cap, and Trimitra Propertindo Tbk. is more actively traded (257.27M versus 963.6K). Which is the better fit depends on your goals.
| DGNS | LAND | |
|---|---|---|
Market Cap | 310.75B | 226.2B |
Volume | 963.6K | 257.27M |
Lot | 9.64K | 2.57M |
Turnover | 217.67M | 21.52B |
Average Price | 225.89 | 83.65 |
Value | 217.67M | 21.52B |
Indicative Equilibrium Price | 226 | 81 |
Indicative Equilibrium Volume | 1K | 26.67K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Trimitra Propertindo Tbk (The Entity) was established based on Notarial Deed of Udin Narsudin, S.H., MKn., No. 46 dated December 13, 2012.
Read more on LAND →